New treatments for multiple sclerosis.
J
J
Poirier
D018450:Disease Progression; D004890:Erythema / Q000139:chemically induced; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D007372:Interferons / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D010146:Pain / Q000139:chemically induced; D010455:Peptides / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate; D007372:Interferons